|
|
|
|
| Researcher develops bioreactor for cultivation of bone cells
Researcher develops bioreactor for cultivation of bone cells
http://www.physorg.com/print194547230.html
A new bioreactor system for cultivating bone cells reduces the number of actions that need to
be taken in the process, and so lowers the cost of tissue culture. Frank Janssen of the
University of Twente (The Netherlands) developed this new bioreactor. With the new system the
cells can be closely monitored during their growth, so that they grow as well as possible.
Sometimes a piece of bone has to be replaced by a new bone fragment, for example after an
accident or illness. Bone tissue culture, where stem cells from the patient's bone marrow are
combined with a suitable carrier material, is a promising technique for this. The method is used
as an alternative for a bone transplant. There were a number of disadvantages to the bone tissue
culture technique, however. Frank Janssen of the University of Twente therefore developed a
special bioreactor in which stem cells from the bone marrow can grow into bone cells. He expects
that the new system will be ready for clinical use in 5 to 10 years.
The new bioreactor for bone tissue culture drastically reduces the number of steps in the
procedure, and therefore lowers its cost. The bioreactor is a closed system, connected to a
computer, so the cultivation conditions such as oxygen use, acidity and temperature can be
tracked online, allowing much better monitoring of cell growth.
Until now, a piece of bone was replaced by an autologous bone transplant, or by using bone
tissue grown in culture jars. In an autologous bone transplant a piece of bone is removed from
another part of the patient's body and placed in the defective area in a surgical operation.
This is a major operation, with a fairly high risk of infection. Bone tissue culture is a good
alternative, but it also has many disadvantages, because it is carried out in culture jars.
These are plastic jars in which a limited number of cells can be cultivated. The technique also
requires many human actions, and the cells cannot be closely monitored during their growing
phase.
Janssen obtained his PhD on 28 May from the faculty of Science and Technology.
May 31, 2010 (PhysOrg.com)
|
|
|
Licenţa de Ministerul Sănătăţii din Ucraina seria AG № 570573 din 10.03.2011
Licenta de Ministerul Sănătăţii din Ucraina seria AB № 511037 din 03.12.2009 ©
Institutul de terapie celulară 2004-2011
|